Ian M. Cook - Colgate-Palmolive Co.
Management
Yeah, good question, Jason. Very strategic. If I take a step back on the portfolio, the full portfolio categories that we have today, as you well know, I think, we have a very sharp priority focus in terms of Oral Care, Pet, Personal, and Home Care in that order, because the underlying growth dynamics in the categories are favorable in that order, consumer loyalty and emotional engagement, therefore pricing, are favorable in that order, and therefore gross margin potential is favorable in that order. And I bring you all the way back to the per capita consumption building programs and education programs we have on toothpaste. So within the portfolio we have today, we have a very clear focus, and obviously even within segments, we're looking to accentuate the premium end of those segments. Disposals, we have done them from time to time, despite the fact that we prioritize our categories the way we do. It's like having four kids. You don't love the fourth any less than the first three, and that's the case with Home Care from our point of view. We have tactically over the years – I think Latin America was the last example where we divested of our bleach business and put it with Clorox as the acquirer, probably a better home for a bleach business than Colgate. So are there small things like that that one might see? Maybe. Your idea of buying on the outside, again, is a good one. It's one we always have in view. We think about it quite broadly, whether it be companies, whether it be brands, or even technology as we have demonstrated in the past. And we put quite a lot of study attention against that. We put our customary financial discipline against that. You're right, we do have the balance sheet flexibility. And if in these volatile times, an external candidate that was attractive, was feeling perhaps a little bit of pressure and looking for a different home, on the assumption the financials would work out, we would be a willing buyer, as we have been with Sanex and Tom's and GABA, all of which have done very well for us. So the answer is, the right brand business saw technology, absolutely, at the right price.